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Objectives 
 Review recommendations from recently published clinical 
guidelines 




Guidelines for Review   
 
 American Diabetes 2015 Standards of Care 
 USPSTF Screening for Thyroid Dysfunction 
 USPSTF Screening for Carotid Artery Stenosis  
 American College of Physicians Diagnosis of OSA 
 American Academy of Pediatrics Fluoride Use in Children 
 Advisory Committee on Immunization Practices 
Pneumococcal Immunization Updates  
 
American Diabetes 2015 
Standards of Care  

Section 2: Classification and 
Diagnosis of Diabetes  
 BMI cut point for screening overweight and obese Asian 
Americans for prediabetes and type 2 diabetes changed from 
25 kg/m2  to 23 kg/m2 
Section 4: Foundations of Care: 
Education, Nutrition, Physical Activity, 
Smoking Cessation, Psychosocial 
Care, and Immunization 
 Limit time spent being sedentary to < 90 minutes at a time 
 E-cigarettes not supported as an alternative to smoking  
 Immunization recommendations updated to include 
recommendations for PCV13 and PPSV23 
Section 6: Glycemic Targets 
 Fasting blood glucose target: 80-130 mg/dL  
  (previously 70-130 mg/dL) 
 
 New recommendations to assess readiness for continuous 
glucose monitoring (CGM)  
Section 7: Approaches to Glycemic 
Treatment 
 Algorithm updated to reflect all currently available therapies 
 

FDA Approved DM2 Medications 
 SGL2 Inhibitors 
 Dapagliflozen (January 2014) 
 Empagliflozen (August 2014) 
 
 GLP1 Receptor Agonists  
 Abliglutide (April 2014) 
 Dulaglutide (April 2014) 
Section 8: Cardiovascular Disease 
and Risk Management 
 Diastolic blood pressure goal: 90 mmHg for most people with 
diabetes and hypertension  
 
 Statin treatment recommendations based on 2013 American 
College of Cardiology/American Heart Association guidelines 
 
 Screening lipid profile recommended at diagnosis, age 40, 
and “periodically thereafter” 
Section 9: Microvascular 
Complications and Foot Care 
 Foot exam at every visit for patients with insensate feet, foot 
deformities, or a history of foot ulcers  
Section 11: Children and 
Adolescents 
 A target A1c of <7.5% is recommended, though 
individualization is encouraged  
Section 12: Management of 
Diabetes in Pregnancy 
 New section with recommendations related to pregnancy and 
diabetes, including preconception counseling, medications, 
blood glucose targets, and monitoring 

JM 
 74 year old female 
 PMH: DM2, HTN, HL, 
osteoporosis 








 Fasting blood glucose log 
 
Date Fasting Blood Glucose  
June 1 72 
June 2 104 
June 3 79 
June 4 97 
June 5 81 
What would you do next? 
(choose all that apply) 
A) Tell her that her diabetes is very well controlled 
B) Review signs/symptoms of hypoglycemia 
C) Discontinue glipizide 
D) Discontinue metformin and glipizide  
What would you do next? 
(choose all that apply) 
A) Tell her that her diabetes is very well controlled 
B) Review signs/symptoms of hypoglycemia 
C) Discontinue glipizide 
D) Discontinue metformin and glipizide  
Summary  
 Diastolic blood pressure and cholesterol guidelines updated 
 Lower end of fasting blood glucose target adjusted to 80 
mg/dL 
 Focus on individualization and patient-centered care 
USPSTF Screening for 
Thyroid Dysfunction 
U.S. Preventive Services Task 
Force 2015 Recommendation  
U.S. Preventive Services Task 
Force 2004 Recommendation  
USPSTF Screening for 
Carotid Artery Stenosis  
U.S. Preventive Services Task 
Force 2014 Recommendation  
U.S. Preventive Services Task 
Force 2007 Recommendation  
American College of 
Physicians Diagnosis of OSA 
 
Recommendation 1: ACP Recommends a sleep 
study for patients with unexplained daytime 
sleepiness 
  Grade: weak recommendation, low-quality 
evidence 
Recommendation 2: ACP recommends 
polysomnography for diagnostic testing in patients 
suspected of obstructive sleep apnea.  ACP 
recommends portable sleep monitors in patients 
without serious comorbidities as an alternative to 
polysomnography when polysomnography is not 
available for diagnostic testing.  
Grade: weak recommendation, moderate quality 
evidence  
ACP Recommendations for OSA 
 Increased emphasis on diagnostic testing for unexplained 
daytime sleepiness  
 Portable monitors may be used in low risk patients  
 Utility of portable monitors for diagnosing OSA in patients 
with comorbid conditions, such as CHF or COPD, unknown 
 
Case: SJ  
 34 year old female 
 PMH: obesity, gestational diabetes  
 SH: Lives with husband and 1 year 
old child  
“I feel so tired 
during the day, 
even when I get 
a lot of sleep.” 
Case: SJ 
TSH, CBC, and Lyme’s tests all 
normal 
 
Sleep hygiene has not decreased 
fatigue 
 
What would you do next? 
A) Order a sleep study 
B) Tell her to drink more coffee 
C) Encourage close follow up and consider further testing if 
symptoms progress or do not improve 
What would you do next? 
A) Order a sleep study 
B) Tell her to drink more coffee 
C) Encourage close follow up and consider further testing if 
symptoms progress or do not improve 
Daytime Sleepiness  
 Sleep study warranted for unexplained daytime sleepiness 
Sleepcenter.org 
American Academy of 
Pediatrics Fluoride Use in 
Children  
 
Dental caries are the most common chronic 
disease of childhood 
Caries (acid produced by bacteria erodes tooth 
enamel) are preventable  
Fluoride has proven effectiveness to decrease 
dental caries 
Fluoride Modalities 
Fluoride Use in Caries Prevention 
 Perform oral health risk assessments on all children 
beginning at 6 months of age 
 Assess a child’s exposure to fluoride and determine the need 
for supplements 
 Understand indications for fluoride varnish 
 Advocate for water fluoridation in the local community  

Oral Health Risk Tools Available 
Brightfutures.aap.org 





Advisory Committee on 
Immunization Practices - 
Recommendations for PCV13 
Vaccine 
All adults 65 years of age or older receive a dose 
of PCV13 followed by a dose of PPSV23 6-12 
months later 
Adults over age 65 who have already received 
PPSV23 at age 65 and older can have PCV13 in 
12 months  
Recommendations for Age 65 or Older  
www.eziz.org 
Recommendations for Age 19 or Older  
www.eziz.org 
Case: RM  
 67 year old female 
 PMH: DM2, HTN, HL 
 Received PPSV23 7 months ago 




What would you tell her? 
A) You have already been immunized for pneumonia and do 
not need another vaccine 
B) You can receive PCV13 today 
C) You should return in 5 months for PCV13 
What would you tell her? 
A) You have already been immunized for pneumonia and do 
not need another vaccine 
B) You can receive PCV13 today 
C) You should return in 5 months for PCV13 
Case  
 37 year old male 
 PMH: Seasonal Allergies, 
Current smoker 
What would you tell him? 
A) He doesn’t meet criteria for either pneumonia vaccine 
B) He should have the new pneumonia vaccine, PCV13, 
followed by PPSV23 in one year 
C) He should be immunized with PPSV23 today 
D) He should have PPSV23 today, followed by PCV13 in one 
year 
 
What would you tell him? 
A) He doesn’t meet criteria for either pneumonia vaccine 
B) He should have the new pneumonia vaccine, PCV13, 
followed by PPSV23 in one year 
C) He should be immunized with PPSV23 today 




 Minimum FBG target changed to 80 mg/dL 
 Sleep studies recommended for those with unexplained 
daytime sleepiness 
 Oral health risk tools and fluoride may help prevent dental 
caries 
 Patients over the age of 65 need PPV13 and PPSV23 
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